If you enjoy this content, please share it with a colleague
RELATED CONTENT
August 27, 2014 — The American Society for Radiation Oncology (ASTRO) has selected San Francisco Bay Area resident and cancer survivor Jasan Zimmerman to receive the 2014 Survivor Circle Award. Mr. Zimmerman will be presented with his award, including $1,000, during the awards ceremony on Tuesday, Sept. 16, at ASTRO’s 56th annual meeting at San Francisco’s Moscone Center.
August 6, 2014 — Standardizing prescribing practices for single-fraction radiation therapy (SFRT) for palliation of bone metastases could lead to cost savings and improvement in patients' quality of life, according to a study published in the Aug. 1 edition of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
August 4, 2014 — A two-step decision tree analysis, incorporating Donabedian’s model, is a feasible process to evaluate and distill the many available quality standards, guidelines, recommendations and indicators in order to update national and international quality standards for radiation therapy, according to a study published in the July/August 2014 issue of Practical Radiation Oncology (PRO).
July 11, 2014 — The American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) announced the launch of RO-ILS, or Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care.
The American Society for Radiation Oncology (ASTRO) has issued a new model policy for proton beam therapy (PBT) that details which cancer diagnoses meet ASTRO’s evidence-based standards and should be covered by private insurers and Medicare.
The American Society for Radiation Oncology (ASTRO) is concerned by the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) April 30, 2014 recommendation to the Centers for Medicare and Medicaid Services (CMS) that adults at high risk for lung cancer should not receive Medicare coverage of annual, low-dose computed tomography (LDCT) screening.
The American Society for Radiation Oncology (ASTRO) released a report that recommends critical areas of biological basic research that would most advance the clinical benefits of radiation oncology.
The North Shore-LIJ Health System Department of Radiation Medicine presented a study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology (ASTRO).
Patients receiving radiotherapy (RT) for cancers in the pelvic region can experience diarrhea, a negative side effect of radiation treatment. Sulfasalazine, an oral tablet used to treat inflammation of the bowels, had been shown in a past trial of 31 patients to decrease diarrhea during pelvic RT. Sulfasalazine does not reduce diarrhea, according to research presented today at the American Society of Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also determined that the medication might be associated with a higher risk of diarrhea than placebo.